TLX Telix Pharmaceuticals Limited
Pharmaceuticals, Biotechnology & Life Sciences
Next annual general meeting
Around Thursday 20 May 2027
Estimated 52 weeks after the last AGM. This will update when the company announces its date or lodges its notice of meeting.
Last AGM voting results
Results of the AGM held Thursday 21 May 2026.
| # | Resolution | For | Against | Result |
|---|---|---|---|---|
| 02 | ADOPT THE | 95.61% | 4.39% | carried |
| 03A | RE-ELECT DR. MARK NELSON AS DIRECTOR | 97.27% | 2.73% | carried |
| 03B | ELECT DAVID GILL AS DIRECTOR | 99.91% | 0.09% | carried |
| 03C | ELECT WILLIAM JELLISON AS DIRECTOR | 99.88% | 0.12% | carried |
| 03D | ELECT DR. MARIA RIVAS AS DIRECTOR APPROVE THE GRANT OF DEFERRED SHARE | 99.90% | 0.10% | carried |
| 04A | RIGHTS TO THE MD & CEO AS PART OF HIS ANNUAL LONG-TERM VARIABLE REMUNERATION FOR THE FINAN | 96.52% | 3.48% | carried |
| 04B | SHARE APPRECIATION RIGHTS TO THE MD & CEO AS HIS ANNUAL LONG-TERM VARIABLE REMUNERATION FO | 96.76% | 3.24% | carried |
| 05 | APPROVE THE EQUITY INCENTIVE PLAN AND THE ISSUE OF EQUITY SECURITIES UNDER THE EQUITY INCE | 87.83% | 12.17% | carried |
| 06 | APPROVE POTENTIAL TERMINATION BENEFITS | 98.88% | 1.12% | carried |
| 07 | APPROVE AN INCREASE TO THE MAXIMUM AGGREGATE REMUNERATION FOR NON EXECUTIVE DIRECTORS | 85.83% | 14.17% | carried |
| 08A | APPROVE THE GRANT OF SHARE APPRECIATION RIGHTS TO NON-EXECUTIVE DIRECTOR - MARIE MCDONALD | 65.02% | 34.98% | carried |
| 08B | APPROVE THE GRANT OF SHARE APPRECIATION RIGHTS TO NON-EXECUTIVE DIRECTOR - DAVID GILL UNDE | 65.02% | 34.98% | carried |
| 08C | APPROVE THE GRANT OF SHARE APPRECIATION RIGHTS TO NON-EXECUTIVE DIRECTOR - WILLIAM JELLISO | 65.02% | 34.98% | carried |
| 08D | APPROVE THE GRANT OF SHARE APPRECIATION RIGHTS TO NON-EXECUTIVE DIRECTOR - DR. MARIA RIVAS | 65.39% | 34.61% | carried |
| 09 | RATIFY THE PRIOR ISSUE OF CONVERTIBLE BONDS | 98.24% | 1.76% | carried |
Protest vote: 20% or more against, or not carried.